Can tumor location predict effectiveness of bevacizumab conducted in the first-line setting for metastatic colorectal cancer

Ann Oncol. 2014 Feb;25(2):545-6. doi: 10.1093/annonc/mdt569. Epub 2014 Jan 12.

Authors

K Y You¹, Y H Gao

Affiliation

¹ Department of Radiation Oncology, State Key Laboratory of Oncology in Southern China, Sun Yat-sen University Cancer Center, Guangzhou, China.

PMID: 24419236
DOI: 10.1093/annonc/mdt569

No abstract available

Publication types

Letter
Comment

MeSH terms

Angiogenesis Inhibitors / therapeutic use*
Antibodies, Monoclonal, Humanized / therapeutic use*
Colorectal Neoplasms / drug therapy*
Colorectal Neoplasms / mortality*
Female
Humans
Male

Substances

Angiogenesis Inhibitors
Antibodies, Monoclonal, Humanized